Useless Valuation Van Leeuwenhoeck Institute initiates Research Coverage, page-67

Nice post legume

This brings about a topic that is of interest to me and that is valuing some of these biotechs particularly when you should be receiving around 5 to 8 percent return per year and if they are 5 years away from making a profit if they are lucky they have a long way to go before they are a productive investment.

I would be interested in hearing your constructive thoughts and reasons on how much of a chance you think osl have on achieving ce mark. Sorry made the assumption you were a doctor.